Medco Buys VC-Backed DNA Direct
Medco Health Solutions Inc. (NYSE: MHS) has acquired DNA Direct Inc., a San Francisco-based genomics utilization management company. No financial terms were disclosed. DNA Direct had raised VC funding from Firefly Investments and Lemhi Ventures.
2 February 2010•4 mins read
